<table xmlns="urn:hl7-org:v3" xmlns:voc="http://www.hl7.org/v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><caption>Table 1Relative and Absolute Risk Seen in the CE/MPA Substudy of WHI<sup>a</sup></caption>
<thead>
<tr><td>Event<sup>c</sup></td><td align="center">Relative Risk <br/>CE/MPA vs.</td><td align="center" valign="bottom">Placebo <br/><content stylecode="underline">n=8,102</content></td><td align="center" valign="bottom">CE/MPA <br/><content stylecode="underline">n=8,506</content></td></tr>
</thead>
<tbody>
<tr><td valign="bottom"><br/></td><td align="center" valign="bottom">Placebo at 5.2 Years <br/>(95%CI)*</td><td align="center" colspan="2" valign="bottom">Absolute Risk per <br/>10,000 Woman–Years</td></tr>
<tr><td stylecode="Toprule " valign="bottom">CHD Events</td><td align="center" stylecode="Toprule " valign="bottom">1.29 (1.02–1.63)</td><td align="right" stylecode="Toprule " valign="bottom">30</td><td align="right" stylecode="Toprule " valign="bottom">37</td></tr>
<tr><td valign="bottom">   Non–fatal MI</td><td align="center" valign="bottom">1.32 (1.02–1.72)</td><td align="right" valign="bottom">23</td><td align="right" valign="bottom">30</td></tr>
<tr><td valign="bottom">   CHD Death</td><td align="center" valign="bottom">1.18 (0.70–1.97)</td><td align="right" valign="bottom">6</td><td align="right" valign="bottom">7</td></tr>
<tr><td valign="bottom">Invasive Breast Cancer<sup>b</sup></td><td align="center" valign="bottom">1.26 (1.00–1.59)</td><td align="right" valign="bottom">30</td><td align="right" valign="bottom">38</td></tr>
<tr><td valign="bottom">Stroke</td><td align="center" valign="bottom">1.41 (1.07–1.85)</td><td align="right" valign="bottom">21</td><td align="right" valign="bottom">29</td></tr>
<tr><td valign="bottom">Pulmonary Embolism</td><td align="center" valign="bottom">2.13 (1.39–3.25)</td><td align="right" valign="bottom">8</td><td align="right" valign="bottom">16</td></tr>
<tr><td valign="bottom">Colorectal Cancer</td><td align="center" valign="bottom">0.63 (0.43–0.92)</td><td align="right" valign="bottom">16</td><td align="right" valign="bottom">10</td></tr>
<tr><td valign="bottom">Endometrial Cancer</td><td align="center" valign="bottom">0.83 (0.47–1.47)</td><td align="right" valign="bottom">6</td><td align="right" valign="bottom">5</td></tr>
<tr><td valign="bottom">Hip Fracture</td><td align="center" valign="bottom">0.66 (0.45–0.98)</td><td align="right" valign="bottom">15</td><td align="right" valign="bottom">10</td></tr>
<tr><td valign="bottom">Death due to causes other <br/>than the events above</td><td align="center" valign="bottom">0.92 (0.74–1.14)</td><td align="right" valign="bottom">40</td><td align="right" valign="bottom">37</td></tr>
<tr><td valign="bottom">Global Index<sup>c</sup></td><td align="center" valign="bottom">1.15 (1.03–1.28)</td><td align="right" valign="bottom">151</td><td align="right" valign="bottom">170</td></tr>
<tr><td valign="bottom">Deep Vein Thrombosis<sup>d</sup></td><td align="center" valign="bottom">2.07 (1.49–2.87)</td><td align="right" valign="bottom">13</td><td align="right" valign="bottom">26</td></tr>
<tr><td valign="bottom">Vertebral Fractures<sup>d</sup></td><td align="center" valign="bottom">0.66 (0.44–0.98)</td><td align="right" valign="bottom">15</td><td align="right" valign="bottom">9</td></tr>
<tr><td valign="bottom">Other Osteoporotic <br/>Fractures</td><td align="center" valign="bottom">0.77 (0.69–0.86)</td><td align="right" valign="bottom">170</td><td align="right" valign="bottom">131</td></tr>
</tbody>
</table>